Rowe Neurology Institute and the MidAmerica Neuroscience Research Foundation

Center Information

John Hunter, PsyD
Executive Director
Rowe Neurology Institute/MidAmerica Neuroscience Research Foundation
8550 Marshall Dr. Suite 100
Lenexa, KS 66214
P: 913-647-8000

D: 913-827-4216
F: 913-827-4266

Currently Enrolling Trials

[Show More]

Therapeutic Areas

Cardiology/Vascular Diseases
Family Medicine
Internal Medicine
Nutrition and Weight Loss
Pulmonary/Respiratory Diseases


Rowe Neurology Institute (RNI)/MidAmerica Neuroscience Research Foundation (not-for-profit) (MANRF) is an independent clinical research site located in the Kansas City Metropolitan Area. MANRF has extensive research, spanning decades, of both basic science research as well as clinical research (participating in over 150 clinical trials). The institute is directed by Medical Director, Vernon D. Rowe III, MD. who is an NIH trained researcher with over 3 decades of research experience. In addition, the clinical research program at MANRF is comprised of 3- Principle investigators; 4 sub-investigators; 1 Neuropsychologist, 3 mid-level providers, and 4 full-time dedicated clinical research coordinators. Our facility consists of:

  • 4 exam rooms
  • 2 infusion rooms
  • Outpatient Neurology Offices
  • Dedicated Laboratory Facility
  • Dedicated Monitoring Office with WiFi access and copier
  • On-site licensed Psychologist/Neuropsychologist
  • On-site licensed Pharmacist
  • Ability to use central IRB


RNI/MANRF conducts principal investigator-initiated research as well as sponsored clinical research trials. We have experience in the following areas:

  • Multiple Sclerosis (MS)
  • Neuromyelitis Optica (NMO)
  • Dementia Disorders
  • Alzheimer’s Disease (AD)
  • Lewy Body Dementia (LBD)
  • Vascular Dementia
  • Stroke
  • Sleep Medicine
  • Obstructive Sleep Apnea
  • Restless Legs Syndrome (RLS)
  • Insomnia
  • Migraine Headache
  • Movement Disorders
  • Hypermobility

We have worked with the following sponsors and contract research organizations:

  • AAI Pharma/Janssen
  • Abbott
  • AbbVie
  • Actelion
  • Adamas Pharmaceuticals
  • Alkermes
  • Allergan
  • Amgen
  • Astra Zeneca International
  • Avanir Pharmaceuticals
  • Axome Therapeutics
  • Axovant
  • Balance Therapeutics
  • Berlex Laboratories
  • Biogen Idec
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Cefaly Technology
  • Chugai Pharmaceuticals
  • Cognition Pharmaceuticals LLC
  • Covance
  • Diiachi Sankyo
  • Eisai
  • Elan Pharmaceuticals
  • Eli Lilly
  • Genentech
  • Genomics Collaborative
  • Genzyme
  • GlaxoSmithKline
  • Hoffman LaRoche
  • i3 Research
  • Icon Clinical Research
  • Idorsia
  • Immune Tolerance Network
  • Impax Laboratories, Inc.
  • INC Research
  • Janssen
  • Jazz
  • Kendle International, Inc.
  • Luitpold Pharmaceuticals
  • MDS Pharma Services
  • MedDay
  • MedPace
  • Merck & Co, Inc.
  • NCGS
  • NMT Medical
  • Novartis Pharmaceuticals
  • Ono Pharmaceuticals
  • Opexa Therapeutics
  • Osmatica Pharmaceuticals
  • Pharma Frountiers
  • PharmaNet
  • PRA International
  • Premier Research
  • Pfizer
  • PPD, Inc.
  • Quintiles, Inc.
  • Receptos
  • Roche
  • EMD Serono
  • Saegis Pharmaceuticals
  • Sanofi-Aventis
  • Schwarz Pharma
  • Sention
  • SunPharma
  • Takeda Pharmaceuticals
  • Teva NeuroScience
  • TorreyPines Therapeutics
  • UCB Pharma Inc.
  • Xenoport, Inc.
  • Yamanouchi Pharma Ltd.



RNI/MANRF is located in Lenexa, Kansas toward the southwest corner of the Kansas City Metropolitan area. The 15-county Kansas City Metropolitan area is the 27th largest in the United States with an estimated population of 1,967,405. The research program is a handicap accessible medical clinic well equipped and conveniently located near major highways, and approximately 30 minutes from an international airport.

RNI/MANRF works closely with local Sleep Center is accredited by the American Academy of Sleep Medicine and Advance Imaging Centers for those needs in clinical trials.

Facility Amenities

  • Comfortable reception area equipped with television
  • Four fully equipped examination rooms
  • Analog and digital connections for data upload
  • Emergency medications, AED, and supplemental oxygen
  • Monitoring facilities include:
  • High-speed wireless internet access
  • Dedicated office space
  • Access to telephone and photocopier
  • CLIA waived laboratory processing center to include:
  • Secure -20 freezer
  • Secure refrigerators
  • Refrigerated centrifuge
  • Ambient swing arm centrifuge
  • On-site dry ice
  • IATA certified staff for shipping requirements
  • Full service CLIA and CAP approved local clinical laboratory
  • Pharmacy to include:
  • 24-hour web-based monitoring of all investigational product storage
  • Customizable alarm settings for investigational product monitoring
  • Double-locked storage facilities
  • Laminar flow hood for sterile medication preparation
  • Locked storage for study supplies, subject data, and paper-based regulatory documents
  • Equipment calibration and maintenance program
  • MERGE clinical trial management system and recruitment database
  • Complete Standard Operating Procedures (SOP)
  • COMPLION electronic regulatory system for off-site access of all site regulatory documents


Our team of experienced investigators, coordinators, and administrative professionals bring knowledge, skill, quality, and a commitment to the research participant in every research trial in which we participate. Our investigators include:

Vernon D. Rowe III, MD

Before founding the institute in 1982, Dr. Vernon D. Rowe earned his BS and MD degrees at Duke University. He served his internship at Harborview Hospital in Seattle and obtained his neurology residency training at Johns Hopkins in Baltimore.

Rowe then served as a research associate at the National Institutes of Health in developmental neurobiology. Rowe next joined the faculty at the University of Kansas Medical School in the Department of Neurology as an associate professor. At KU he taught and mentored medical students and residents and carried out basic research on neuron-target interactions, funded by grants from the National Institutes of Health, the Veterans Administration, and the March of Dimes Foundation. The author of numerous research publications, Rowe is currently an adjunct professor of neurology at the University of Kansas Medical School. Certifications include neurology and in sleep medicine, as well as electro-myography, electroencephalography, and neuro-MRI. His professional affiliations include the American Medical Association, the American Academy of Neurology, the American Academy of Sleep Medicine, the American Board of Electrodiagnostic Medicine, the Society for Neuroscience, and the American Society for Neurochemistry. He was also the Founder and & CEO for Verrow Pharmaceuticals which developed his patents around a kidney safe contrast agent (2008-2018) when it was acquired by Ligand Pharmaceuticals.  He is licensed in Missouri, Kansas, and North Carolina.

Haseeb Ahmed, DO

Dr. Ahmed, an internal medicine physician, joined the RNI clinical research team in 2017. Dr. Ahmed attended DesMoines University where he earned his DO as well as a master’s in health administration. He completed his internal medicine residency at the University of Kansas Medical Center in Kansas City, KS. His experience includes the following: Board-certified in Internal Medicine, Hospital Medicine, Medical Director of Blood Conservation Program, Found of Anemia Clinic, Assistant Professor UMKC School of Medicine, Author of review article, research studies, and textbooks.

Mayank Gupta, MD

Dr. Mayank Gupta is a board-certified, fellowship-trained Interventional Pain Management Physician.  He is the president and CEO of American Society of Interventional Pain, Kansas and served as the President of the House Staff Association at John H. Stroger Cook County Hospital in Chicago, IL.  He also served as Vice President of the National Union of Hospital and Health Care Employees (NUHHE).

Dr. Gupta has a special interest and experience in the management of facial pain, migraine headaches, complex back and neck pain with failed surgery.  With his expertise, he offers advanced procedures, including ultrasound-guided peripheral nerve stimulation and radiofrequency ablation.  He is one of a few physicians in the country to perform ultrasound guided occipital nerve radiofrequency ablation for headaches and radiofrequency of splanchnic nerve for chronic abdominal pain and chronic pancreatitis.  His current clinical medical practice focuses on complex spinal procedures, implantable devices, therapeutic BOTOX injections for migraine headaches and cervical dystonia, kyphoplasty and radiofrequency ablation.

Abraham Rafie, MD

Dr. Abraham Rafie received his medical degree from the University of Texas Medical Branch in 2004. Following an internship at the Methodist Hospital in Houston, he completed a diagnostic radiology residency at the University of Texas Health Science Center San Antonio. In 2010, Dr. Rafie completed an emergency radiology fellowship at Brigham & Women’s Hospital in Boston. Since then Dr. Rafie has been in private practice with a mixed inpatient and outpatient practice.

Amanda Owens, FNP-BC, APRN

Amanda is board-certified Advance Practice Registered Nurse. She has practiced in allergy, immunology and primary care before coming to MANRF in 2019.

She has a special interest in Multiple Sclerosis, dementia and migraine and enjoys helping patients improve their quality of life with treatment. She graduated from the University of Kansas School of Nursing with a Bachelor of Science in Nursing and then Masters of Science in Nursing.

Melissa Harnsberger, PA-C

Melissa is board-certified Physician Assistant. She has practiced in allergy, immunology and primary care before coming to MANRF in 2019.

She has a special interest in Cardiology, Multiple Sclerosis, and primary care. She also has spent several years in clinical research in multiple areas.  She graduated from the Texas Christian University with a Bachelors in Psychosocial Kinesiology and a minor in Psychology and Advertising and Public Relations.  She then completed a Master of Health Sciences with Physician Assistant Certification from Duke University.

Nissa Fisher, APRN

Nissa Fisher attended MidAmerica Nazarene University and received her bachelor’s in nursing.   She then earned a Master of Science in Nursing from Research College of Nursing with a concentration in Family Nurse Practitioner Studies.  She is board certified by the American Academy of Nurse Practitioners.  Ms. Fisher has a strong Neuro background with previous experience in stroke and neurosurgery.

Jane Cowee, BASc. R.Ph.

Jane attended the University of Kansas and received a Bachelor of Applied Sciences (BASc) in Pharmacology.  She later became a registered pharmacist.  She was a pharmacist at Olathe Medical Center from 2001-2006. She has contracted with several pharmaceutical companies and is listed on two patents with regard to use of cyclodextrins.  She currently is a Clinical Pharmacist with Tria Health and has contracted with MANRF since 2008.

Amelia Winsby, PsyD

Dr. Amelia Winsby practices Clinical Neuropsychology at the Pinnacle Regional Hospital Neurology Services, conducting neuropsychological evaluations for a variety of precipitating issues, including dementia, multiple sclerosis, sleep disorders, head injuries, seizure activity and stroke/TIA. In addition to neuropsychological evaluations, Dr. Winsby is available for the following evaluations: medical-behavioral evaluations such as pre-surgical bariatric assessments and chronic pain assessments, mood and personality assessments, and behavioral assessments. Dr. Winsby also contracts with MANRF and serves as an neuropsychological evaluator for clinical trials.

Dr. Winsby completed a bachelor’s degree in Psychology and a bachelor’s degree in Applied Behavioral Sciences at the University of Kansas, in Lawrence KS. At the University of Missouri in Kansas City in the Biomedical and Health Informatics research lab, she published research related to tobacco cessation in the military. Dr. Winsby completed both her master’s degree in Clinical Psychology and a doctorate degree in Clinical Psychology at Forest Institute in Springfield, Missouri. She spent her internship and residency years specializing in clinical and neurocognitive assessments, medical psychology, and integrated care. Dr. Winsby has conducted research and published in the field of bariatric psychology and has served on a peer review panel for several professional journals.  Dr. Winsby also conducts forensic evaluation in the state of West Virginia.  She is licensed in Kansas, Missouri and West Virginia.

John Hunter, PsyD

Dr. John A. Hunter is Executive Director of MANRF and takes a strong interest in research. He completed his undergraduate education at CBC in Kansas City, Missouri, and graduate studies in psychology at Illinois State University and Roosevelt University in Chicago. He received his doctorate in clinical psychology from the Forest Institute in Chicago. He has managed healthcare organizations since the 1970’s and has been a business consultant to both public and private companies. Prior to joining the RNI/MANRF, he was the chief executive officer and hospital administrator for a hospital in Kansas City, Missouri.  He was also the VP of Clinical Affairs for Verrow Pharmaceuticals (2008-2018) when it was acquired by Ligand Pharmaceuticals.  He has published research on multiple sclerosis, sleep, migraine/headache, psychological assessments and stroke.

Clinical Research Coordinators

Dan Magee, BS, CCRC: (913) 827-4212
Carol Carrolton, MS, CRC (913) 827-4260 
Priyanka Tadikonda, MS, CRC (913) 827-4272

Lindsay Kriemendahl, CRC (913) 827-4242

Clinical Research Support Staff

Leigh A. Kreshel, MS, CCRC Senior Research Consultant

Elizabeth Rowe, PhD, MBA, Senior Research Advisor

Tammy Tubbs, BA, RT(R)(CV)(MR), Imaging Liaison

Maria Helms, HR, Bookkeeping, Administration

Jeff Majerus, IT Administrator


Rowe Neurology Institute uses a central IRB. The turn-around time in submitting all regulatory documentation averages 2 - 7 days. We accomplish the regulatory process in approximately two weeks with expedited completion possible. Contract budgets typically finalized within a week.

As our research studies in neurology are constantly changing, for the most accurate information on our currently-enrolling clinical studies and to find out if you qualify, please fill out the form found here.

Contact Center

If you are interested in contacting this center to discuss clinical trials, please complete and send the email form below. A representative from the research center will then follow up with you.